JP2020505324A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505324A5 JP2020505324A5 JP2019534141A JP2019534141A JP2020505324A5 JP 2020505324 A5 JP2020505324 A5 JP 2020505324A5 JP 2019534141 A JP2019534141 A JP 2019534141A JP 2019534141 A JP2019534141 A JP 2019534141A JP 2020505324 A5 JP2020505324 A5 JP 2020505324A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- peptide
- composition according
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762442441P | 2017-01-05 | 2017-01-05 | |
| US62/442,441 | 2017-01-05 | ||
| US201762481702P | 2017-04-05 | 2017-04-05 | |
| US62/481,702 | 2017-04-05 | ||
| US201762557153P | 2017-09-12 | 2017-09-12 | |
| US62/557,153 | 2017-09-12 | ||
| PCT/IL2018/050012 WO2018127914A1 (en) | 2017-01-05 | 2018-01-04 | Peptides for treating sjogren's syndrome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505324A JP2020505324A (ja) | 2020-02-20 |
| JP2020505324A5 true JP2020505324A5 (https=) | 2021-02-12 |
| JP7242059B2 JP7242059B2 (ja) | 2023-03-20 |
Family
ID=61157250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534141A Active JP7242059B2 (ja) | 2017-01-05 | 2018-01-04 | シェーグレン症候群の治療用ペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11167005B2 (https=) |
| EP (1) | EP3565574A1 (https=) |
| JP (1) | JP7242059B2 (https=) |
| CN (1) | CN110139659B (https=) |
| AU (1) | AU2018205885A1 (https=) |
| CA (1) | CA3047706A1 (https=) |
| IL (1) | IL267426B2 (https=) |
| WO (1) | WO2018127914A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116287183B (zh) * | 2022-11-18 | 2023-11-03 | 中国医学科学院北京协和医院 | 一组用于诊断干燥综合征的分子标志物组合 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6613536B1 (en) | 1995-03-28 | 2003-09-02 | Yeda Research And Development Co. Ltd. | Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| IL141647A0 (en) * | 2001-02-26 | 2002-03-10 | Yeda Res & Dev | Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| JP2006516034A (ja) | 2003-01-14 | 2006-06-15 | テバ ファーマシューティカル インダストリーズ リミティド | 全身性エリテマトーデスを治療するためのペプチドの非経口製剤 |
| KR20050100617A (ko) | 2003-01-14 | 2005-10-19 | 테바 파마슈티컬 인더스트리즈 리미티드 | 전신 홍반 루푸스 치료용 펩티드의 비 경구 제형 |
| AU2005276117C1 (en) * | 2004-08-23 | 2013-04-18 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Peptide inhibitors for mediating stress responses |
| WO2007142667A2 (en) * | 2005-10-13 | 2007-12-13 | Human Genome Sciences, Inc. | Treatment of patients with autoantibody positive disease |
| WO2008087647A2 (en) * | 2007-01-19 | 2008-07-24 | Yeda Research And Development Co. Ltd. | Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle) |
| US9833519B2 (en) | 2012-09-25 | 2017-12-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for the diagnosis and treatment of sjögren's syndrome |
| US20180043016A1 (en) | 2016-08-11 | 2018-02-15 | Xtl Biopharmaceuticals Ltd. | Pharmaceutical compositions comprising 0.25 mg dose of synthetic human peptides for treating systemic lupus erythematosus |
| US20180043017A1 (en) | 2016-08-11 | 2018-02-15 | Xtl Biopharmaceuticals Ltd. | Pharmaceutical compositions comprising 0.5 mg dose of synthetic human peptides for treating systemic lupus erythematosus |
-
2018
- 2018-01-04 CA CA3047706A patent/CA3047706A1/en active Pending
- 2018-01-04 US US16/474,831 patent/US11167005B2/en not_active Expired - Fee Related
- 2018-01-04 JP JP2019534141A patent/JP7242059B2/ja active Active
- 2018-01-04 CN CN201880005934.0A patent/CN110139659B/zh not_active Expired - Fee Related
- 2018-01-04 AU AU2018205885A patent/AU2018205885A1/en not_active Abandoned
- 2018-01-04 EP EP18703096.0A patent/EP3565574A1/en not_active Withdrawn
- 2018-01-04 IL IL267426A patent/IL267426B2/en unknown
- 2018-01-04 WO PCT/IL2018/050012 patent/WO2018127914A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6084207B2 (ja) | 虚血性脳損傷及び疼痛治療用の効率的な神経保護剤としてのｐｓｄ−９５の高親和性二量体阻害剤 | |
| RU2194054C2 (ru) | Синтетические аналоги il-10 | |
| KR101184833B1 (ko) | Ｈｃｇ 절편들을 포함하는 점막 및 경구 투여용 조성물 | |
| JP2012506442A5 (https=) | ||
| BRPI0912411B1 (pt) | Uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune | |
| NO326298B1 (no) | Anvendelse av R'-Glu-Trp-R'' dipeptider i fremstilling av medikamenter | |
| JP2019533722A5 (https=) | ||
| JP7213811B2 (ja) | 新規なステープルペプチドおよびその使用 | |
| JP2006506942A5 (https=) | ||
| EP2540737B1 (fr) | Utilisation de ligands synthétiques multivalents de la nucléoline de surface pour le traitement de l'inflammation | |
| JP2023145635A (ja) | 免疫調節特性を有するペプチド | |
| ES2660894T3 (es) | Péptidos derivados de ezrina y composiciones farmacéuticas de los mismos | |
| CN110114060A (zh) | 具有杀菌作用的制剂 | |
| US20050075277A1 (en) | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects | |
| JP2020505324A5 (https=) | ||
| RU2010120571A (ru) | Тимус-специфический белок | |
| ES2338350T3 (es) | Utilizacion de hsp20 para estimular la cicatrizacion de heridas y/o para reducir la formacion de cicatrices. | |
| CN107805282A (zh) | 一种靶向疗法和免疫疗法联合的多肽 | |
| CN108117594A (zh) | 促进细胞迁移及/或皮肤伤口愈合的肽、含该肽的医药组合物及其用途 | |
| CN114080394A (zh) | 新型θ-防御素类似物 | |
| JP2021531246A5 (https=) | ||
| CN111788217A (zh) | 白介素-15活性的拮抗剂肽 | |
| JP7242059B2 (ja) | シェーグレン症候群の治療用ペプチド | |
| CN111574590B (zh) | 一种具有抗肿瘤功能的多肽及其应用 | |
| CN119874872B (zh) | 一种mita铰链区突变多肽及其在自身免疫性疾病中的应用 |